Micrus Endovascular Corp (NASDAQ:MEND)

patnglen (< 20) Submitted: 7/2/2010 5:24:54 PM : Start Price: $21.75 MEND Score: -20.01

MEND's prospects are founded on innovative science and good management.

donsguesswork (< 20) Submitted: 12/3/2009 9:32:55 PM : Start Price: $14.16 MEND Score: +46.93

MEND, AN EXCELLENT SYMBOL CHOICE FOR A COMPANY THAT DEVELOPS. MANUFACTURES AND MARKETS IMPLANTABLE AND DISPOSABLE DEVICES THAT TREAT CEREBAL VASCULAR DISEASES, THE ENTERPRISE EXTENDS ACROSS THE AMERICAN, EUROPE, AND ASIA. SECOND QTR NI OF $3.6 MIL COMPARED TO A $2.7 MIL LOSS 08, EPS .22, EST 0F .06. GROWTH WAS FUELED BY NEW PRODUCTS AND SELLING NEW ACCOUNTS. TOTAL CASH INCREASED TO$24.3 MIL.

brentan0 (60.16) Submitted: 10/22/2007 11:37:57 AM : Start Price: $19.07 MEND Score: +30.05

This stock got hammered in mid September when they revised their revenue outlook. They were only reporting earnings delays however, and the overall earnings outlook is rosy.

kferg126 (44.32) Submitted: 5/12/2007 6:23:22 AM : Start Price: $21.48 MEND Score: +16.22

rapidly increasing sales. stock down on delay in approval for Chinese market. strong candidate for buyout or independent success. no debt.

centxsooner (< 20) Submitted: 4/5/2007 12:53:05 PM : Start Price: $24.10 MEND Score: -0.05

Very limited market. No earnings. Am I missing something here?

msamet1 (88.32) Submitted: 3/30/2007 10:22:56 AM : Start Price: $24.20 MEND Score: +1.49

Cost containment pressures and reimbursement issues will keep profits down with limited upside growth; niched market

pjmckee (21.45) Submitted: 3/20/2007 11:22:51 PM : Start Price: $22.50 MEND Score: +4.89

point and figure double breakout. stock should go up from here.